Mark F. McLaughlin

Statistics

Publications

Citations

369

H-Index

Active since

1964

Affiliations

The University of Texas Southwestern Medical Center(Current)

University of Missouri

University of Tennessee at Knoxville

Oak Ridge National Laboratory

Mark F. McLaughlin is an author at The University of Texas Southwestern Medical Center specializing in surgical oncology, urology, and radiation therapy.

ORCID

Top concepts

UrologyMedicineOncologyRadiotherapySurgical OncologyRadiation OncologyChemistryEngineeringCatalysisNanomedicine

Publications per year

1964–2023

Publications

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy

Mark F. McLaughlin, Jonathan Woodward, R. A. Boll et al. · PLoS ONE · 2013 · 119 citations · Full text

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer

Raquibul Hannan, Mark F. McLaughlin, Laurentiu M. Pop et al. · European Urology · 2023 · 56 citations · Full text

Urology, Surgical Oncology, Primary Renal Cancer +7

LnPO <sub>4</sub> Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy

Mark F. McLaughlin, David J. Robertson, Paul H. Pevsner et al. · Cancer Biotherapy and Radiopharmaceuticals · 2013 · 47 citations

Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy

Mark F. McLaughlin, Michael R. Folkert, Robert Timmerman et al. · Advances in Radiation Oncology · 2021 · 37 citations · Full text

Gold-coated lanthanide phosphate nanoparticles for an <sup>225</sup>Ac in vivo alpha generator

Mark F. McLaughlin, John M. Woodward, R. A. Boll et al. · Radiochimica Acta · 2013 · 33 citations

Nanoparticles, Engineering, Metal Nanoparticles +20

1–5 of 9